Tehran University of Medical Sciences

Science Communicator Platform

Share By
Genetic Spectrum Among 2009 Iranian Individuals With Neuromuscular Disorders Using Next Generation Sequencing and Multiple Ligation Dependent Probe Amplification Methods Publisher Pubmed



Molaei N ; Alagha P ; Khanbazi A ; Beheshtian M ; Ahangari F ; Dehdahsi S ; Fadaee M ; Ashki M ; Ghaderi Z ; Elahi Z ; Vazehan R ; Parsimehr E ; Nouri MM ; Saei P Show All Authors
Authors
  1. Molaei N
  2. Alagha P
  3. Khanbazi A
  4. Beheshtian M
  5. Ahangari F
  6. Dehdahsi S
  7. Fadaee M
  8. Ashki M
  9. Ghaderi Z
  10. Elahi Z
  11. Vazehan R
  12. Parsimehr E
  13. Nouri MM
  14. Saei P
  15. Noudehi K
  16. Fatehi F
  17. Najafabadi SZ
  18. Abolhassani A
  19. Afroozan F
  20. Yazdan H
  21. Kelishomi MA
  22. Azad M
  23. Parvini F
  24. Kassaee SM
  25. Ramezani M
  26. Zemorshidi F
  27. Salimipour H
  28. Abdi S
  29. Bakhshandeh M
  30. Fayyazi A
  31. Zamani G
  32. Ashrafi MR
  33. Jamali P
  34. Sarraf P
  35. Okhovat AA
  36. Ashtiani BH
  37. Fatehi F
  38. Karimzadeh P
  39. Nafissi S
  40. Kahrizi K
  41. Kariminejad A
  42. Najmabadi H

Source: Scientific Reports Published:2025


Abstract

Hereditary neuromuscular disorders (NMDs) are clinically and genetically heterogeneous, with variable severity and onset from birth to adulthood. This study retrospectively analyzes genetic findings in 2009 Iranian individuals with suspected NMDs over 11 years to highlight gene involvement and mutational patterns. Patients underwent gene panel sequencing (GPS), whole exome sequencing (WES), or MLPA for PMP22 in cases with suspected Charcot-Marie-Tooth disease type 1 A (CMT1A). The diagnostic yield of GPS/WES was 46%. Dystrophies were the most prevalent, followed by neuropathies and myopathies. The key implicated genes were CAPN3 and DMD for dystrophies; GDAP1 and MME for neuropathies; GNE and ETFDH for myopathies. The most common phenotype group was dystrophies among both individuals with childhood-onset and adulthood-onset, but the most frequent mutated gene was CAPN3 in children and DYSF in adults. Identified variants include 761 (97%) single nucleotide variants (SNVs) and 24 (3%) copy number variations (CNVs). Notably, 26% of SNVs were novel. Among individuals tested with MLPA, 28% had confirmed PMP22 gene deletions or duplications, with 73% being duplications linked to CMT1A. This large-scale analysis provides insight into the genetic landscape of NMDs in Iran. Understanding gene distribution and mutation types can improve diagnosis and inform management strategies for affected individuals. © The Author(s) 2025.
Related Docs
View other Related Docs
1. Molecular Diagnosis of Hereditary Neuropathies by Whole Exome Sequencing and Expanding the Phenotype Spectrum, Archives of Iranian Medicine (2020)
2. The Genetic Basis of Early-Onset Hereditary Ataxia in Iran: Results of a National Registry of a Heterogeneous Population, Human Genomics (2024)
3. Genetic Analysis of Forty Mlpa-Negative Duchenne Muscular Dystrophy Patients by Whole-Exome Sequencing, Journal of Molecular Neuroscience (2022)
Experts (# of related papers)
View all Related Experts
Mahmoudreza Ashrafi (9)
Gholamreza Zamani Ghalehtaki (6)
Other Related Docs
4. Diagnostic Whole Exome Sequencing in Presumably Autosomal Recessive Inherited Retinal Dystrophies in an Iranian Population, Scientific Reports (2025)
5. The First Comprehensive Cohort of the Duchenne Muscular Dystrophy in Iranian Population: Mutation Spectrum of 314 Patients and Identifying Two Novel Nonsense Mutations, Journal of Molecular Neuroscience (2020)
6. A Comprehensive Study of Mutation and Phenotypic Heterogeneity of Childhood Mitochondrial Leukodystrophies, Brain and Development (2024)
7. Nemaline Myopathy: Reclassification of Previously Reported Variants According to Acmg Guidelines, and Report of Novel Genetic Variants, European Journal of Human Genetics (2023)
8. Clinical and Molecular Spectrum of an Iranian Charcot-Marie-Tooth 2T Cohort, and the Diagnostic Importance of Whole Exome Sequencing in Identifying Co-Occurrence Inherited Disorders, Neuromuscular Disorders (2026)
9. Three Novel Variants Identified in Fbn1 and Tgfbr2 in Seven Iranian Families With Suspected Marfan Syndrome, Molecular Genetics and Genomic Medicine (2020)
10. High Genetic Heterogeneity of Leukodystrophies in Iranian Children: The First Report of Iranian Leukodystrophy Registry, Neurogenetics (2023)
11. Clinical Application of Next Generation Sequencing for Mendelian Disease Diagnosis in the Iranian Population, npj Genomic Medicine (2024)
12. The Spectrum of Atm Gene Mutations in Iranian Patients With Ataxia-Telangiectasia, Pediatric Allergy and Immunology (2021)
13. Genetic and Clinical Insights Into Pontocerebellar Hypoplasia: Identification of Novel Variants in an Iranian Cohort, European Journal of Medical Genetics (2026)
14. Identification of Two Rare Variants in Iranian Families With Familial Sudden Cardiac Death, International Journal of Genomics (2026)
15. Genetic Mutations and Immunological Features of Severe Combined Immunodeficiency Patients in Iran, Immunology Letters (2019)
16. A Novel Missense Variant in Gpt2 Causes Non-Syndromic Autosomal Recessive Intellectual Disability in a Consanguineous Iranian Family, European Journal of Medical Genetics (2020)
17. A Comprehensive Overview of Smn and Naip Copy Numbers in Iranian Sma Patients, Scientific Reports (2023)
18. Causative Variants Linked With Limb Girdle Muscular Dystrophy in an Iranian Population: 6 Novel Variants, Molecular Genetics and Genomic Medicine (2023)
19. Genotype-Phenotype Correlation and Description of Two Novel Mutations in Iranian Patients With Glycogen Storage Disease 1B (Gsd1b), Orphanet Journal of Rare Diseases (2020)
20. Lgmd2e Is the Most Common Type of Sarcoglycanopathies in the Iranian Population, Journal of Neurogenetics (2017)